gusperimus has been researched along with Atresia, Biliary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Katoh, H; Ohi, R; Ohkohchi, N; Satomi, S; Shimaoka, S | 1 |
| Asakura, T; Doi, H; Fujimori, K; Katoh, H; Kawagishi, N; Kikuchi, H; Koyamada, N; Ohkohchi, N; Oikawa, K; Orii, T; Sakurada, M; Satake, M; Satomi, S; Takayama, J | 1 |
1 trial(s) available for gusperimus and Atresia, Biliary
| Article | Year |
|---|---|
Living related partial liver transplantation in biliary atresia: 11 cases of experience.
Topics: ABO Blood-Group System; Biliary Atresia; Child, Preschool; Female; Graft Rejection; Guanidines; Histocompatibility; Humans; Immunosuppressive Agents; Infant; Japan; Liver Transplantation; Living Donors; Male; Postoperative Complications; Survival Rate; T-Lymphocytes; Tacrolimus | 1997 |
1 other study(ies) available for gusperimus and Atresia, Biliary
| Article | Year |
|---|---|
Living related liver transplantation in patients with ABO incompatibility.
Topics: ABO Blood-Group System; Biliary Atresia; Blood Group Incompatibility; Child; Child, Preschool; Cyclosporine; Drug Administration Schedule; Female; Guanidines; Humans; Immunosuppressive Agents; Infant; Liver Transplantation; Living Donors; Male; Muromonab-CD3; Parents; Plasma Exchange; Plasmapheresis; Tacrolimus | 1998 |